Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor.
Saved in:
| Title: | Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor. |
|---|---|
| Authors: | Burghaus R; Bayer HealthCare Wuppertal, Germany., Coboeken K; Bayer Technology Services GmbH Leverkusen, Germany., Gaub T; Bayer Technology Services GmbH Leverkusen, Germany., Niederalt C; Bayer Technology Services GmbH Leverkusen, Germany., Sensse A; Bayer HealthCare Wuppertal, Germany., Siegmund HU; Bayer Technology Services GmbH Leverkusen, Germany., Weiss W; Bayer Technology Services GmbH Leverkusen, Germany., Mueck W; Bayer HealthCare Wuppertal, Germany., Tanigawa T; Bayer HealthCare Wuppertal, Germany., Lippert J; Bayer HealthCare Wuppertal, Germany. |
| Source: | Frontiers in physiology [Front Physiol] 2014 Nov 07; Vol. 5, pp. 417. Date of Electronic Publication: 2014 Nov 07 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-042X |
|---|---|
| DOI: | 10.3389/fphys.2014.00417 |
